| Health / Medical Topics |
Gp96 heat shock protein-peptide complex vaccine
Pronunciation
A vaccine made from a patient’s tumor cells that may help the body’s immune system kill cancer cells. This vaccine is used to treat kidney cancer, a type of brain cancer called glioma, and metastatic melanoma (a type of skin cancer that has spread). It is also being studied in the treatment of other types of cancer. Also called gp96 HSP-peptide complex, Oncophage, and vitespen. (NCI Dictionary)
YOU MAY ALSO LIKE
A modified peptide antigen derived from gp209, with potential immunomodulatory and antineoplastic activities. gp209-2M antigen (IMDQVPFSV) has a methionine substitution of threonine…
A peptide (short piece of protein) made from the tumor-specific antigen gp100, and used to make vaccines being studied in the treatment…
A vaccine containing a HER2/Neu-derived epitope (amino acids 654-662) (GP2), and combined with granulocyte-macrophage colony-stimulating factor (GM-CSF), with potential antineoplastic and immunoadjuvant…
A synthetic peptide consisting of amino acid residues 614 through 622 of the melanoma-melanocyte antigen glycoprotein 100 (gp100). Vaccination with gp100:614-622 peptide…
A synthetic peptide vaccine consisting of the amino acids 44 through 59 of the glycoprotein 100 (gp100) melanoma antigen. Vaccination with…
A peptide vaccine consisting of the amino acids 280 through 288 of the melanoma antigen glycoprotein 100 (gp100) with potential antineoplastic…
